1 rich Libsyn https://www.libsyn.com 300 600 🩺 Beyond Diabetes, Beyond Albuminuria, Beyond Expectations: Finerenone Across the CKD Spectrum 🚀 Major advance in nephrology and cardiorenal medicine! &amp;nbsp; The INFINITY pooled analysis (14,574 participants) demonstrates that finerenone reduces CKD progression, kidney failure, heart failure hospitalization, cardiovascular death, and even all-cause mortality across a broad spectrum of chronic kidney disease—not just type 2 diabetes. 🩺❤️🩺 &amp;nbsp; Benefits were remarkably consistent across glycemic status, CKD etiology, eGFR, albuminuria, and SGLT2 inhibitor use. Hyperkalemia remains the key safety consideration but serious events were uncommon. &amp;nbsp; Could finerenone become a foundational therapy for CKD regardless of diabetes status? 🔬📈 &amp;nbsp; #CKD #Nephrology #Cardiology #Finerenone #CardioRenal #MedicalPodcasts #INFINITYTrial #KidneyDisease #HeartFailure #PrecisionMedicine Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity! http://www.MasterMedFacts.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41641675/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/202954265